Form 8-K - Current report:
SEC Accession No. 0001193125-25-056725
Filing Date
2025-03-18
Accepted
2025-03-18 17:04:06
Documents
53
Period of Report
2025-03-18
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.02: Results of Operations and Financial Condition
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d925335d8k.htm   iXBRL 8-K 164921
2 EX-3.1 d925335dex31.htm EX-3.1 4816
3 EX-3.2 d925335dex32.htm EX-3.2 22890
4 EX-3.3 d925335dex33.htm EX-3.3 94811
5 EX-10.3 d925335dex103.htm EX-10.3 52008
6 EX-10.4 d925335dex104.htm EX-10.4 274135
7 EX-10.5 d925335dex105.htm EX-10.5 288481
8 EX-10.6 d925335dex106.htm EX-10.6 61519
9 EX-10.7 d925335dex107.htm EX-10.7 59703
10 EX-10.8 d925335dex108.htm EX-10.8 451987
11 EX-21.1 d925335dex211.htm EX-21.1 2118
12 EX-23.1 d925335dex231.htm EX-23.1 2055
13 EX-99.1 d925335dex991.htm EX-99.1 14354
14 EX-99.2 d925335dex992.htm EX-99.2 530267
15 EX-99.3 d925335dex993.htm EX-99.3 264712
16 EX-99.4 d925335dex994.htm EX-99.4 151349
17 EX-99.5 d925335dex995.htm EX-99.5 407304
18 EX-99.6 d925335dex996.htm EX-99.6 180390
23 GRAPHIC g925335d106.jpg GRAPHIC 107250
24 GRAPHIC g925335d107.jpg GRAPHIC 85104
25 GRAPHIC g925335d108.jpg GRAPHIC 169242
26 GRAPHIC g925335g0315224732835.jpg GRAPHIC 14107
27 GRAPHIC g925335g0315224733225.jpg GRAPHIC 8105
28 GRAPHIC g925335g0315224733420.jpg GRAPHIC 12001
29 GRAPHIC g925335g0315224733615.jpg GRAPHIC 5390
30 GRAPHIC g925335g0315224733887.jpg GRAPHIC 23546
31 GRAPHIC g925335g0315224734142.jpg GRAPHIC 11573
32 GRAPHIC g925335g0315224734428.jpg GRAPHIC 23136
33 GRAPHIC g925335g0315224734731.jpg GRAPHIC 18632
34 GRAPHIC g925335g0315224734972.jpg GRAPHIC 8206
35 GRAPHIC g925335g0315224735197.jpg GRAPHIC 7753
36 GRAPHIC g925335g0315224735482.jpg GRAPHIC 19092
37 GRAPHIC g925335g0315224735809.jpg GRAPHIC 19573
38 GRAPHIC g925335g0315224736109.jpg GRAPHIC 26195
39 GRAPHIC g925335g0315224736455.jpg GRAPHIC 17697
40 GRAPHIC g925335g0315224736801.jpg GRAPHIC 15711
41 GRAPHIC g925335g0315224737151.jpg GRAPHIC 17198
42 GRAPHIC g925335g0315224737556.jpg GRAPHIC 27256
43 GRAPHIC g925335g0315224738399.jpg GRAPHIC 16247
44 GRAPHIC g925335g0316045733001.jpg GRAPHIC 2014
  Complete submission text file 0001193125-25-056725.txt   4790397

Data Files

Seq Description Document Type Size
19 XBRL TAXONOMY EXTENSION SCHEMA klrs-20250318.xsd EX-101.SCH 3219
20 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE klrs-20250318_def.xml EX-101.DEF 14628
21 XBRL TAXONOMY EXTENSION LABEL LINKBASE klrs-20250318_lab.xml EX-101.LAB 24183
22 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE klrs-20250318_pre.xml EX-101.PRE 15564
55 EXTRACTED XBRL INSTANCE DOCUMENT d925335d8k_htm.xml XML 5864
Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301 650-249-2727
Kalaris Therapeutics, Inc. (Filer) CIK: 0001754068 (see all company filings)

EIN.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 25749367
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)